In the present study we confirmed that Cx43 levels decrease at the epithelial migrating edge, but also showed that further transient downregulation with Cx43-specific AsODN significantly increased the rate of wound closure. Our AsODN delivery studies indicated that Cx43 AsODN accumulated in the stroma beneath the wound and at the wound leading edge of the epithelium, where Cx43 protein knockdown should therefore primarily occur. This profile indeed correlated with the reduction in Cx43 levels at the wound edge compared with untreated controls, as seen by immunohistochemistry, and was consistent with a faster wound closure observed with in vivo confocal microscopy, fluorescein staining, and histologic analysis. In addition, we analyzed Cx43 in the stroma after wounding, where it was initially lost immediately below the injury site, probably as a result of cell dieback, but was subsequently upregulated in the stroma both at and peripheral to the wound site. Cx43 AsODN application reduced stromal levels of Cx43, and in parallel reduced edema and inflammation (both cell counts and myofibroblast differentiation), and promoted improved basal lamina repair. It is not possible to carry out Western blot analysis with sampling limited to the affected areas of tissue, and although we have counted the number of immunolabeled gap junctions, this approach does not take into account possible changes in plaque size. However, our healing results are consistent with reports from skin wound studies, where Cx43 downregulation decreased inflammation and edema, and triggered faster epithelial closure.
18,19 It is postulated that downregulation of Cx43 with specific AsODN may enhance corneal wound healing by a dual mechanism: increased epithelial cell migration and decreased stromal swelling and inflammation. Reduced Cx43 levels in the epithelium may enable cells to differentiate into a migratory phenotype to close the wound, as occurs with skin epidermal keratinocytes.
18 Lower Cx43 levels in the stroma lead to reduced edema, which is thought to be associated with Cx43 hemichannel opening,
32 as well as reduced inflammation and bystander-mediated lesion spread. The spreading of proinflammatory responses through Cx43 gap junctions has been reported in lung endothelial cells.
33 Similarly here, proinflammatory signals appear to be spreading between keratocytes. This would explain why proliferation and myofibroblast differentiation deep beneath and peripheral to the lesion seen in control wounded animals are reduced with Cx43 AsODN treatment. The sensitivity of the fluorescence tag technique means that we cannot entirely exclude the possibility that some AsODN has reached the endothelium. However, the transient knockdown of Cx43 appears to have a limited effect on connexin levels in unwounded tissues,
34 with the major effect being where Cx43 levels are changing in the first hours after injury. The same Cx43 AsODN has been used previously by Nakano et al.
35 to study endothelial wound healing, but we did not observe any effects on the endothelium, which was unwounded in our study.